2-(methoxyamino)-8-[(2R)-2-methyl-1-(1-methylcyclopropanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-6-(4-methyl-2-oxo-2λ6-thia-3-azabicyclo[2.1.0]pent-1-en-2-yl)-3-[(1-methylpyrazol-4-yl)methyl]quinazolin-4-one

C29H35N7O4S — CID 170744325

IUPAC2-(methoxyamino)-8-[(2R)-2-methyl-1-(1-methylcyclopropanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-6-(4-methyl-2-oxo-2λ6-thia-3-azabicyclo[2.1.0]pent-1-en-2-yl)-3-[(1-methylpyrazol-4-yl)methyl]quinazolin-4-one
SMILESCONc1nc2c(C3=CCN(C(=O)C4(C)CC4)[C@H](C)C3)cc(S3(=O)=C4CC4(C)N3)cc2c(=O)n1Cc1cnn(C)c1
InChIInChI=1S/C29H35N7O4S/c1-17-10-19(6-9-35(17)26(38)28(2)7-8-28)21-11-20(41(39)23-13-29(23,3)33-41)12-22-24(21)31-27(32-40-5)36(25(22)37)16-18-14-30-34(4)15-18/h6,11-12,14-15,17H,7-10,13,16H2,1-5H3,(H,31,32)(H,33,39)/t17-,29?,41?/m1/s1
InChIKeyXFNUUOPZYGYHBX-GJMHBKKXSA-N
MW577.71 g/mol
LogP2.45
Rot. Bonds7

About 2-(methoxyamino)-8-[(2R)-2-methyl-1-(1-methylcyclopropanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-6-(4-methyl-2-oxo-2λ6-thia-3-azabicyclo[2.1.0]pent-1-en-2-yl)-3-[(1-methylpyrazol-4-yl)methyl]quinazolin-4-one

2-(methoxyamino)-8-[(2R)-2-methyl-1-(1-methylcyclopropanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-6-(4-methyl-2-oxo-2λ6-thia-3-azabicyclo[2.1.0]pent-1-en-2-yl)-3-[(1-methylpyrazol-4-yl)methyl]quinazolin-4-one (PubChem CID 170744325) has the molecular formula C29H35N7O4S and a molecular weight of 577.71 g/mol. Its IUPAC name is 2-(methoxyamino)-8-[(2R)-2-methyl-1-(1-methylcyclopropanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-6-(4-methyl-2-oxo-2λ6-thia-3-azabicyclo[2.1.0]pent-1-en-2-yl)-3-[(1-methylpyrazol-4-yl)methyl]quinazolin-4-one.

Molecular Properties

Compound Name2-(methoxyamino)-8-[(2R)-2-methyl-1-(1-methylcyclopropanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-6-(4-methyl-2-oxo-2λ6-thia-3-azabicyclo[2.1.0]pent-1-en-2-yl)-3-[(1-methylpyrazol-4-yl)methyl]quinazolin-4-one
PubChem CID170744325
Molecular FormulaC29H35N7O4S
Molecular Weight577.71 g/mol
Exact Mass577.25
IUPAC Name2-(methoxyamino)-8-[(2R)-2-methyl-1-(1-methylcyclopropanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-6-(4-methyl-2-oxo-2λ6-thia-3-azabicyclo[2.1.0]pent-1-en-2-yl)-3-[(1-methylpyrazol-4-yl)methyl]quinazolin-4-one
SMILESCONc1nc2c(C3=CCN(C(=O)C4(C)CC4)[C@H](C)C3)cc(S3(=O)=C4CC4(C)N3)cc2c(=O)n1Cc1cnn(C)c1
InChIInChI=1S/C29H35N7O4S/c1-17-10-19(6-9-35(17)26(38)28(2)7-8-28)21-11-20(41(39)23-13-29(23,3)33-41)12-22-24(21)31-27(32-40-5)36(25(22)37)16-18-14-30-34(4)15-18/h6,11-12,14-15,17H,7-10,13,16H2,1-5H3,(H,31,32)(H,33,39)/t17-,29?,41?/m1/s1
InChIKeyXFNUUOPZYGYHBX-GJMHBKKXSA-N
XLogP2.45
TPSA123.38 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms41
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500577.71
LogP ≤ 52.45
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'thio_ketone(43)', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze 2-(methoxyamino)-8-[(2R)-2-methyl-1-(1-methylcyclopropanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-6-(4-methyl-2-oxo-2λ6-thia-3-azabicyclo[2.1.0]pent-1-en-2-yl)-3-[(1-methylpyrazol-4-yl)methyl]quinazolin-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(methoxyamino)-8-[(2R)-2-methyl-1-(1-methylcyclopropanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-6-(4-methyl-2-oxo-2λ6-thia-3-azabicyclo[2.1.0]pent-1-en-2-yl)-3-[(1-methylpyrazol-4-yl)methyl]quinazolin-4-one?
The IUPAC name of 2-(methoxyamino)-8-[(2R)-2-methyl-1-(1-methylcyclopropanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-6-(4-methyl-2-oxo-2λ6-thia-3-azabicyclo[2.1.0]pent-1-en-2-yl)-3-[(1-methylpyrazol-4-yl)methyl]quinazolin-4-one (CID 170744325) is 2-(methoxyamino)-8-[(2R)-2-methyl-1-(1-methylcyclopropanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-6-(4-methyl-2-oxo-2λ6-thia-3-azabicyclo[2.1.0]pent-1-en-2-yl)-3-[(1-methylpyrazol-4-yl)methyl]quinazolin-4-one.
What is the SMILES notation for 2-(methoxyamino)-8-[(2R)-2-methyl-1-(1-methylcyclopropanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-6-(4-methyl-2-oxo-2λ6-thia-3-azabicyclo[2.1.0]pent-1-en-2-yl)-3-[(1-methylpyrazol-4-yl)methyl]quinazolin-4-one?
The canonical SMILES for 2-(methoxyamino)-8-[(2R)-2-methyl-1-(1-methylcyclopropanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-6-(4-methyl-2-oxo-2λ6-thia-3-azabicyclo[2.1.0]pent-1-en-2-yl)-3-[(1-methylpyrazol-4-yl)methyl]quinazolin-4-one is CONc1nc2c(C3=CCN(C(=O)C4(C)CC4)[C@H](C)C3)cc(S3(=O)=C4CC4(C)N3)cc2c(=O)n1Cc1cnn(C)c1.
What is the InChIKey of 2-(methoxyamino)-8-[(2R)-2-methyl-1-(1-methylcyclopropanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-6-(4-methyl-2-oxo-2λ6-thia-3-azabicyclo[2.1.0]pent-1-en-2-yl)-3-[(1-methylpyrazol-4-yl)methyl]quinazolin-4-one?
The InChIKey is XFNUUOPZYGYHBX-GJMHBKKXSA-N. The full InChI is InChI=1S/C29H35N7O4S/c1-17-10-19(6-9-35(17)26(38)28(2)7-8-28)21-11-20(41(39)23-13-29(23,3)33-41)12-22-24(21)31-27(32-40-5)36(25(22)37)16-18-14-30-34(4)15-18/h6,11-12,14-15,17H,7-10,13,16H2,1-5H3,(H,31,32)(H,33,39)/t17-,29?,41?/m1/s1.
What are the key properties of 2-(methoxyamino)-8-[(2R)-2-methyl-1-(1-methylcyclopropanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-6-(4-methyl-2-oxo-2λ6-thia-3-azabicyclo[2.1.0]pent-1-en-2-yl)-3-[(1-methylpyrazol-4-yl)methyl]quinazolin-4-one?
2-(methoxyamino)-8-[(2R)-2-methyl-1-(1-methylcyclopropanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-6-(4-methyl-2-oxo-2λ6-thia-3-azabicyclo[2.1.0]pent-1-en-2-yl)-3-[(1-methylpyrazol-4-yl)methyl]quinazolin-4-one has a molecular weight of 577.71 g/mol, XLogP of 2.45, 7 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(methoxyamino)-8-[(2R)-2-methyl-1-(1-methylcyclopropanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-6-(4-methyl-2-oxo-2λ6-thia-3-azabicyclo[2.1.0]pent-1-en-2-yl)-3-[(1-methylpyrazol-4-yl)methyl]quinazolin-4-one is sourced from PubChem (CID 170744325), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).